Representatives from the Mashayekhi Lab participated in the Annual Meeting of the American Association of Immunologists (AAI), held May 3–7, 2025, at the Hawaiʻi Convention Center in Honolulu. Postdoctoral fellow Ilkin Safa, MD, presented a research poster. The presentation highlighted the lab's findings that SGLT2 inhibitors may reduce cardiovascular risk by decreasing monocyte-platelet aggregates (MPAs).